670 results District Court ruled on the recognition of the res judicata effect of a Turkish judgment and dismissed an antitrust follow on damages claim regarding the cathode-ray tube markets The District Court of Oost-Brabant recognized the res judicata effect of a Turkish court of appeal judgment, in which the Turkish court had dismissed antitrust damages claims brought by Vestel against Philips, Samsung, LGE, Technicolor, TTD and TDP. Stibbe advises Palex Medical Stibbe is advising Palex Medical, a Spain-based company specialising in high value-added MedTech equipment and solutions, on its planned acquisition of Duomed, a fast-growing European MedTech distributor. Egbert Vroom Partner Amsterdam Stibbe assists Rhône with its partnership with Orkla Stibbe assisted investment vehicles affiliated with Rhône Capital on a partnership with Orkla whereby Rhône acquired 40% of the shares in Orkla Food Ingredients (OFI). Stibbe advises Goed A multidisciplinary Stibbe team advised Goed and its shareholders on its binding agreement with Mulitpharma relating to the sale of Goed’s pharmaceutical retail and wholesale business. The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite. Digital antitrust conduct: too elusive to catch? The ink on the Digital Market Act has barely dried, but fast-evolving digital developments already have competition authorities calling for new tools. Is Big Tech not kept in check by the DMA, the antitrust rules and the EU Merger Regulation after all? The Foreign Subsidies Regulation’s initial focus on China Although the text of the Foreign Subsidies Regulation is not aimed at specific countries, the European Commission’s initial enforcement actions appear to be targeting Chinese subsidies. Stibbe advises Corsair Capital Stibbe has advised Corsair Capital, a leading private equity firm specialising in payments, software, and business services investments on the acquisition of a majority stake in MJM Holdings. Third time lucky: Intel wins loyalty rebate battle at EU top court The European Court of Justice has upheld the annulment of Intel’s EUR 1.06 billion fine for abuse of dominance. The judgment provides guidance on how to assess the anti-competitiveness of loyalty rebates. If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug. Tekst & Commentaar Mededingingsrecht Roos Elemans en Jurriaan van Gent droegen bij aan de nieuwe uitgave van Tekst & Commentaar Mededingingsrecht. Mede dankzij deze bijdrage kunnen (mededingings-)juristen actief op het gebied van investeringstoetsingen nu gebruikmaken van dit naslagwerk. Van procederen kun je leren? Rechterlijke toetsing van concentratiezaken in Nederland Roos Elemans en Simone Evans staan in een artikel voor het Tijdschrift Mededingingsrecht in de Praktijk stil bij de vraag: wel of geen beroep instellen tegen een concentratiebesluit? De Europese Commissie, de Staat en de (inter)nationale rechter: een staatssteunrechtelijk 'Game of Thrones' of checks and balances? De staatssteunrechtelijke bevoegdhedenverdeling tussen de Europese Commissie, de Staat en de rechter houdt de gemoederen bezig. Een voorbeeld hiervan biedt de Micula rechtspraak over investeringsarbitrage. Deze blog bespreekt dergelijke zaken. Stibbe Amsterdam appoints three new partners We are pleased to announce that Stibbe Amsterdam has promoted Roos Elemans, Lotte Hover-Boon and Daisy Nijkamp to partner effective 1 January 2025. These appointments will further strengthen our EU and Competition Law, Tax and Litigation practices. EU lift cartel damage claim rejected by Brussels Court of Appeal After 16 years of court battle, the Brussels Court of Appeal has rejected the EU’s EUR 12 million (+ interest) damage claim against the four lift producers that participated in the lift cartel fined in 2007. Stibbe represents Mercedes-Benz in class action concerning NOx emissions from diesel vehicles Stibbe is acting as defence counsel for Mercedes-Benz in mass litigation over allegations that the company installed prohibited defeat devices in its diesel-powered vehicles. Stibbe represented Vodafone in mass litigation concerning "all-in" subscriptions Stibbe acted as defence counsel for the telecom service provider Vodafone in mass litigation initiated by the Dutch Consumer Association (Consumentenbond). Pagination Previous page Page 12 Current page 13 Page 14 Page 15 Next page
District Court ruled on the recognition of the res judicata effect of a Turkish judgment and dismissed an antitrust follow on damages claim regarding the cathode-ray tube markets The District Court of Oost-Brabant recognized the res judicata effect of a Turkish court of appeal judgment, in which the Turkish court had dismissed antitrust damages claims brought by Vestel against Philips, Samsung, LGE, Technicolor, TTD and TDP.
Stibbe advises Palex Medical Stibbe is advising Palex Medical, a Spain-based company specialising in high value-added MedTech equipment and solutions, on its planned acquisition of Duomed, a fast-growing European MedTech distributor.
Stibbe assists Rhône with its partnership with Orkla Stibbe assisted investment vehicles affiliated with Rhône Capital on a partnership with Orkla whereby Rhône acquired 40% of the shares in Orkla Food Ingredients (OFI).
Stibbe advises Goed A multidisciplinary Stibbe team advised Goed and its shareholders on its binding agreement with Mulitpharma relating to the sale of Goed’s pharmaceutical retail and wholesale business.
The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite.
Digital antitrust conduct: too elusive to catch? The ink on the Digital Market Act has barely dried, but fast-evolving digital developments already have competition authorities calling for new tools. Is Big Tech not kept in check by the DMA, the antitrust rules and the EU Merger Regulation after all?
The Foreign Subsidies Regulation’s initial focus on China Although the text of the Foreign Subsidies Regulation is not aimed at specific countries, the European Commission’s initial enforcement actions appear to be targeting Chinese subsidies.
Stibbe advises Corsair Capital Stibbe has advised Corsair Capital, a leading private equity firm specialising in payments, software, and business services investments on the acquisition of a majority stake in MJM Holdings.
Third time lucky: Intel wins loyalty rebate battle at EU top court The European Court of Justice has upheld the annulment of Intel’s EUR 1.06 billion fine for abuse of dominance. The judgment provides guidance on how to assess the anti-competitiveness of loyalty rebates.
If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug.
Tekst & Commentaar Mededingingsrecht Roos Elemans en Jurriaan van Gent droegen bij aan de nieuwe uitgave van Tekst & Commentaar Mededingingsrecht. Mede dankzij deze bijdrage kunnen (mededingings-)juristen actief op het gebied van investeringstoetsingen nu gebruikmaken van dit naslagwerk.
Van procederen kun je leren? Rechterlijke toetsing van concentratiezaken in Nederland Roos Elemans en Simone Evans staan in een artikel voor het Tijdschrift Mededingingsrecht in de Praktijk stil bij de vraag: wel of geen beroep instellen tegen een concentratiebesluit?
De Europese Commissie, de Staat en de (inter)nationale rechter: een staatssteunrechtelijk 'Game of Thrones' of checks and balances? De staatssteunrechtelijke bevoegdhedenverdeling tussen de Europese Commissie, de Staat en de rechter houdt de gemoederen bezig. Een voorbeeld hiervan biedt de Micula rechtspraak over investeringsarbitrage. Deze blog bespreekt dergelijke zaken.
Stibbe Amsterdam appoints three new partners We are pleased to announce that Stibbe Amsterdam has promoted Roos Elemans, Lotte Hover-Boon and Daisy Nijkamp to partner effective 1 January 2025. These appointments will further strengthen our EU and Competition Law, Tax and Litigation practices.
EU lift cartel damage claim rejected by Brussels Court of Appeal After 16 years of court battle, the Brussels Court of Appeal has rejected the EU’s EUR 12 million (+ interest) damage claim against the four lift producers that participated in the lift cartel fined in 2007.
Stibbe represents Mercedes-Benz in class action concerning NOx emissions from diesel vehicles Stibbe is acting as defence counsel for Mercedes-Benz in mass litigation over allegations that the company installed prohibited defeat devices in its diesel-powered vehicles.
Stibbe represented Vodafone in mass litigation concerning "all-in" subscriptions Stibbe acted as defence counsel for the telecom service provider Vodafone in mass litigation initiated by the Dutch Consumer Association (Consumentenbond).